107 related articles for article (PubMed ID: 30678450)
1. Expression of Vascular Endothelial Growth Factor and Its Receptors in Thyroid Nodular Hyperplasia and Papillary Thyroid Carcinoma: A Tertiary Health Care Centre Based Study.
Mohamad Pakarul Razy NH; Wan Abdul Rahman WF; Win TT
Asian Pac J Cancer Prev; 2019 Jan; 20(1):277-282. PubMed ID: 30678450
[TBL] [Abstract][Full Text] [Related]
2. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
[No Abstract] [Full Text] [Related]
3. Relationship between expression of vascular endothelial growth factor and cervical lymph node metastasis in papillary thyroid cancer: A meta-analysis.
Huang XQ; He WS; Zhang HQ; Yang R; Huang T
J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):661-666. PubMed ID: 29058277
[TBL] [Abstract][Full Text] [Related]
4. The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis.
Gulcelik NE; Akin S; Aydin K; Aydin Mericoz C; Guler Tezel YG; Usman A
Minerva Endocrinol (Torino); 2023 Dec; 48(4):379-386. PubMed ID: 35775885
[TBL] [Abstract][Full Text] [Related]
5. Expression of NIS, VEGF-A and Thyroid Autoantibody in Papillary Thyroid Carcinoma with or without Hashimoto's Disease.
Ma Y; He J; Shen N; Guo R
ORL J Otorhinolaryngol Relat Spec; 2019; 81(5-6):281-286. PubMed ID: 31480047
[TBL] [Abstract][Full Text] [Related]
6. Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma.
Selemetjev S; Savin S; Paunovic I; Tatic S; Cvejic D
J Cancer Res Ther; 2018; 14(Supplement):S114-S119. PubMed ID: 29578160
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic and lymphangiogenic profiles in histological variants of papillary thyroid carcinoma.
Skuletic V; Radosavljevic GD; Pantic J; Markovic BS; Jovanovic I; Jankovic N; Petrovic D; Jevtovic A; Dzodic R; Arsenijevic N
Pol Arch Intern Med; 2017 Jun; 127(6):429-437. PubMed ID: 28425432
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.
Bingül İ; Vural P; Doğru-Abbasoğlu S; Çil E; Uysal M
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 27925342
[TBL] [Abstract][Full Text] [Related]
10. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
11. Predicting lymph node metastasis in patients with papillary thyroid carcinoma by vascular index on power Doppler ultrasound.
Lee JH; Shin HJ; Yoon JH; Kim EK; Moon HJ; Lee HS; Kwon HJ; Kwak JY
Head Neck; 2017 Feb; 39(2):334-340. PubMed ID: 27704649
[TBL] [Abstract][Full Text] [Related]
12. The Specifically Androgen-Regulated Gene (SARG) Promotes Papillary Thyroid Carcinoma (PTC) Lymphatic Metastasis Through Vascular Endothelial Growth Factor C (VEGF-C) and VEGF Receptor 3 (VEGFR-3) Axis.
Xu SJ; Jin B; Zhao WJ; Chen XX; Tong YY; Ding XF; Chen YY; Wang DH; Wang ZM; Dai BQ; Chen S; Liang Y; Chen G; Pan SJ; Xu LL
Front Oncol; 2022; 12():817660. PubMed ID: 35769717
[TBL] [Abstract][Full Text] [Related]
13. Activity of ecto-5'-nucleotidase (NT5E/CD73) is increased in papillary thyroid carcinoma and its expression is associated with metastatic lymph nodes.
Bertoni APS; Bracco PA; de Campos RP; Lutz BS; Assis-Brasil BM; Meyer ELS; Saffi J; Braganhol E; Furlanetto TW; Wink MR
Mol Cell Endocrinol; 2019 Jan; 479():54-60. PubMed ID: 30184475
[TBL] [Abstract][Full Text] [Related]
14. Correlation between human epidermal growth factor receptor 2 oncoprotein expression and some prognostic factors in papillary thyroid carcinoma.
Rabiee S; Nadoushan MJ; Rayeni NM; Ansari I
Indian J Pathol Microbiol; 2017; 60(3):324-327. PubMed ID: 28937366
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
16. Increased Expression of GARP in Papillary Thyroid Carcinoma.
Zhang X; Guo M; Yang J; Zheng Y; Xiao Y; Liu W; Ren F
Endocr Pathol; 2019 Mar; 30(1):1-7. PubMed ID: 30443770
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructure and histomorphometric analysis of human umbilical cord vessels in preeclampsia: a potential role of VEGF, VEGFR-1 and VEGFR-2.
Almasry SM; Elfayomy AK; Hashem HE
Rom J Morphol Embryol; 2016; 57(2 Suppl):681-689. PubMed ID: 27833959
[TBL] [Abstract][Full Text] [Related]
18. Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients.
Bernatz S; Monden D; Gessler F; Radic T; Hattingen E; Senft C; Seifert V; Ronellenfitsch MW; Plate KH; Harter PN; Baumgarten P
J Mol Histol; 2021 Apr; 52(2):233-243. PubMed ID: 33528717
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide Expression Screening Discloses Long Noncoding RNAs Involved in Thyroid Carcinogenesis.
Liyanarachchi S; Li W; Yan P; Bundschuh R; Brock P; Senter L; Ringel MD; de la Chapelle A; He H
J Clin Endocrinol Metab; 2016 Nov; 101(11):4005-4013. PubMed ID: 27459529
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of soluble HLA-G and cytokines in papillary thyroid carcinoma before and after thyroidectomy.
Bertol BC; de Araújo JNG; Sadissou IA; Sonon P; Dias FC; Bortolin RH; de Figueiredo-Feitosa NL; de Freitas LCC; de Miranda Henrique Tarrapp SR; de Oliveira Ramos CC; Luchessi AD; de Freitas JCOC; Maciel LMZ; Silbiger VN; Donadi EA
Int J Clin Pract; 2020 Oct; 74(10):e13585. PubMed ID: 32534476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
